Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Omnicell launches new automated dispensing system

Medication management company Omnicell has introduced a new generation of automated dispensing systems to improve hospitals' “efficiency, safety and flexibility”.

Omnicell XT Automated Medication Dispensing Cabinet, which launched on January 17, aims to help hospital pharmacy and nursing staff “optimise inventory, minimise stockouts and reduce missed doses”, Omnicell said. 

The new systems will also “fully meet” the minimum GS1 barcoding standards which are due to come into force in 2019-20, it added. 

The new XT cabinets include metal locking lid drawers; supports wireless accessories and has a ‘guiding lights’ feature to help direct users to selected medicines, Omnicell said. 

They are also compatible with current Omnicell G3/G4 cabinet infrastructure, it stressed.

For more information, contact 0161 775 6658

Would automated dispensing improve efficiency in your pharmacy?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel